Validating the M. D. Anderson symptom inventory (MDASI) for use in patients with ovarian cancer

Gynecologic Oncology

Volumn 130, Issue 2, 2013, Pages 323-328

  Sailors, Mary H ^a   Bodurka, Diane C ^a   Gning, Ibrahima ^a   Ramondetta, Lois M ^a   Williams, Loretta A ^a   Mendoza, Tito R ^a   Agarwal, Sonika ^a   Sun, Charlotte C ^a   Cleeland, Charles S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Ovarian cancer MDASI M. D. Anderson Symptom Inventory Symptoms Assessment Validation

Indexed keywords

ANTINEOPLASTIC AGENT;

ABDOMINAL PAIN; ADULT; AGED; ANOREXIA; ARTICLE; BACKACHE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURGERY; CONSTIPATION; CONSTRUCT VALIDITY; CRITERION RELATED VALIDITY; DISEASE SEVERITY; DROWSINESS; DYSPNEA; FATIGUE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; INTERNAL CONSISTENCY; M. D. ANDERSON SYMPTOM INVENTORY; MAJOR CLINICAL STUDY; MEMORY DISORDER; NAUSEA; OVARY CANCER; PARESTHESIA; PATIENT ATTITUDE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SENSITIVITY ANALYSIS; SLEEP DISORDER; SYMPTOM ASSESSMENT; VOMITING; XEROSTOMIA;

ASSESSMENT; M. D. ANDERSON SYMPTOM INVENTORY; MDASI; OVARIAN CANCER; SYMPTOMS; VALIDATION;

ADULT; AGED; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 84880280444     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.05.009     Document Type: Article

References (35)

1. Cancer Facts and Figures 2012. Atlanta: American Cancer Society 2012.
2. B.A. Goff, L.S. Mandel, C.H. Melancon, and H.G. Muntz Frequency of symptoms of ovarian cancer in women presenting to primary care clinics JAMA 291 2004 2705 2712
3. C.S. Cleeland, R. Gonin, A.K. Hatfield, J.H. Edmonson, R.H. Blum, and J.A. Stewart Pain and its treatment in outpatients with metastatic cancer N. Engl. J. Med. 330 1994 592 596
4. J.C. Holland Progress and challenges in psychosocial and behavioral research in cancer in the twentieth century Cancer 67 1991 767 773
5. A. Cull, S. Howat, E. Greimel, A.C. Waldenstrom, J. Arraras, and A. Kudelka Development of a European Organization for Research and Treatment of Cancer questionnaire module to assess the quality of life of ovarian cancer patients in clinical trials: a progress report Eur. J. Cancer 37 2001 47 53
6. E. Greimel, A. Bottomley, A. Cull, A.C. Waldenstrom, J. Arraras, and L. Chauvenet An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer Eur. J. Cancer 39 2003 1402 1408
7. K. Basen-Engquist, D. Bodurka-Bevers, M.A. Fitzgerald, K. Webster, D. Cella, and S. Hu Reliability and validity of the functional assessment of cancer therapy-ovarian J. Clin. Oncol. 19 2001 1809 1817
8. S.E. Jensen, S.K. Rosenbloom, J.L. Beaumont, A. Abernethy, P.B. Jacobsen, and K. Syrjala A new index of priority symptoms in advanced ovarian cancer Gynecol. Oncol. 120 2011 214 219
9. U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Center for Devices and Radiological Health. Guidance for Industry - Patient-Reported Outcome Measures: Use in Medical Product Development to Support Claims. 2006.
10. C.S. Cleeland, T.R. Mendoza, X.S. Wang, C. Chou, M.T. Harle, and M. Morrissey Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory Cancer 89 2000 1634 1646
11. J. Kirkova, M.P. Davis, D. Walsh, E. Tiernan, N. O'Leary, and S.B. LeGrand Cancer symptom assessment instruments: a systematic review J. Clin. Oncol. 24 2006 1459 1473
12. T.S. Armstrong, T. Mendoza, I. Gning, C. Coco, M.Z. Cohen, and L. Eriksen Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT) J. Neurooncol 80 2006 27 35
13. D.I. Rosenthal, T.R. Mendoza, M.S. Chambers, J.A. Asper, I. Gning, and M.S. Kies Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module Head Neck 29 2007 923 931
14. A. Fadol, T. Mendoza, I. Gning, J. Kernicki, L. Symes, and C.S. Cleeland Psychometric testing of the MDASI-HF: a symptom assessment instrument for patients with cancer and concurrent heart failure J. Card. Fail. 14 2008 497 507
15. I. Gning, P.C. Trask, T.R. Mendoza, M.T. Harle, K.A. Gutierrez, and S.A. Kitaka Development and initial validation of the thyroid cancer module of the M.D. Anderson Symptom Inventory Oncology 76 2009 59 68
16. X.S. Wang, L.A. Williams, C. Eng, T.R. Mendoza, N.A. Shah, and K.J. Kirkendoll Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI) Cancer 116 2010 2053 2063
17. T.R. Mendoza, X.S. Wang, C. Lu, G.R. Palos, Z. Liao, and G.M. Mobley Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M.D. Anderson Symptom Inventory Oncologist 16 2011 217 227
18. L.A. Williams, S. Agarwal, D.C. Bodurka, A.K. Saleeba, C.C. Sun, and C.S. Cleeland Capturing the patient's experience: use of qualitative methods for developing a patient-reported measure of symptom burden: an example from ovarian cancer J. Pain Symptom Manage. 2013 http://dx.doi.org/10.1016/j.jpainsymman. 2013.02.007 [in press, Apr 22, Electronic publication ahead of print]
19. J. Bernhard, M. Sullivan, C. Hurny, A.S. Coates, and C.M. Rudenstam Clinical relevance of single item quality of life indicators in cancer clinical trials Br. J. Cancer 84 2001 1156 1165
20. J.A. Sloan, N. Aaronson, J.C. Cappelleri, D.L. Fairclough, and C. Varricchio Assessing the clinical significance of single items relative to summated scores Mayo Clin. Proc. 77 2002 479 487
21. J.A. Sloan, C.L. Loprinzi, S.A. Kuross, A.W. Miser, J.R. O'Fallon, and M.R. Mahoney Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer J. Clin. Oncol. 16 1998 3662 3673
22. M.S. Bartlett Test of significance in factor analysis Br. J. Psychol. 3 1950 77 85
23. H. Kaiser A second generation little jiffy Psychometrika 35 1970 401 415
24. H.H. Harman Modern Factor Analysis 3rd ed. 1976 University of Chicago Press Chicago
25. C.S. Cleeland, J.A. Sloan, D. Cella, C. Chen, A.C. Dueck, and N.A. Janjan Recommendations for including multiple symptoms as endpoints in cancer clinical trials: a report from the ASCPRO Multisymptom Task Force Cancer 119 2012 411 420
26. C.S. Cleeland, and J.A. Sloan Assessing the Symptoms of Cancer Using Patient-Reported Outcomes (ASCPRO): searching for standards J. Pain Symptom Manage. 39 2010 1077 1085
27. C.C. Lin, A.P. Chang, C.S. Cleeland, T.R. Mendoza, and X.S. Wang Taiwanese version of the M. D. Anderson symptom inventory: symptom assessment in cancer patients J. Pain Symptom Manage. 33 2007 180 188
28. K. Mystakidou, C. Cleeland, E. Tsilika, E. Katsouda, A. Primikiri, and E. Parpa Greek M.D. Anderson Symptom Inventory: validation and utility in cancer patients Oncology 67 2004 203 210
29. M. Nejmi, X.S. Wang, T.R. Mendoza, I. Gning, and C.S. Cleeland Validation and application of the Arabic version of the M. D. Anderson symptom inventory in Moroccan patients with cancer J. Pain Symptom Manage. 40 2010 75 86
30. T. Okuyama, X.S. Wang, T. Akechi, T.R. Mendoza, T. Hosaka, and C.S. Cleeland Japanese version of the MD Anderson Symptom Inventory: a validation study J. Pain Symptom Manage. 26 2003 1093 1104
31. X.S. Wang, A.V. Laudico, H. Guo, T.R. Mendoza, M.L. Matsuda, and V.D. Yosuico Filipino version of the M. D. Anderson Symptom Inventory: validation and multisymptom measurement in cancer patients J. Pain Symptom Manage. 31 2006 542 552
32. X.S. Wang, Y. Wang, H. Guo, T.R. Mendoza, X.S. Hao, and C.S. Cleeland Chinese version of the M.D. Anderson Symptom Inventory: validation and application of symptom measurement in cancer patients Cancer 101 2004 1890 1901
33. Y.H. Yun, T.R. Mendoza, I.O. Kang, C.H. You, J.W. Roh, and C.G. Lee Validation study of the Korean version of the M. D. Anderson Symptom Inventory J. Pain Symptom Manage. 31 2006 345 352
34. X.S. Wang, C.S. Cleeland, T.R. Mendoza, Y.H. Yun, Y. Wang, and T. Okuyama Impact of cultural and linguistic factors on symptom reporting by patients with cancer J. Natl. Cancer Inst. 102 2010 732 738
35. C.S. Cleeland Symptom burden: multiple symptoms and their impact as patient-reported outcomes J. Natl. Cancer Inst. Monogr. 2007 16 21